Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 382)
Posted On: 02/11/2019 12:49:14 PM
Post# of 72447
Posted By: Lemoncat
Re: petemantx #53179
I don't think they will need a new tox study unless B dosages are significantly higher. If the oral mucosa, rectum, and direct IV don't have issues, then the skin likely won't either.

Cream formulation is not hard and will probably be outsourced for a trial.

If we have enough money coming in from B milestones we might be able to take the topical all the way to NDA ourselves. They tend to be the cheapest trials due to simplicity and safety.

I wont begin to guess on Kevetrin timelines.













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site